A Fluidic Biosensor Based on a Phase-Sensitive Low-Coherence Spectral-Domain Interferometer

Cuixia Guo, Xiaojie Yang, Zhiyuan Shen, Jian-Ping Wu, Suyi Zhong, Yonghong He, Tian Guan, Fangyi Chen

TL;DR

This paper introduces a novel fluidic biosensor that leverages phase-sensitive low-coherence spectral-domain interferometry to detect molecular binding events with subnanometric precision and millisecond response times. This advancement offers a label-free, highly sensitive, and rapid method for monitoring molecular interactions, crucial for applications in diagnostics and drug discovery.

What Problem Does This Paper Address?

Accurate and rapid detection of molecular interactions is fundamental across various scientific disciplines, including medical diagnostics, drug screening, and environmental monitoring. While label-based methods are common, they often require complex procedures and can potentially alter the target molecules. Label-free methods offer a more direct approach, providing insights into molecular dynamics like binding kinetics and affinity. However, existing label-free techniques, such as surface plasmon resonance (SPR) and electrochemical methods, have limitations in sensitivity, susceptibility to environmental fluctuations, or require bulky instrumentation. This paper addresses the need for a highly sensitive, real-time, and robust label-free biosensing platform that can detect subtle changes in molecular layers with high temporal resolution.

Methods

The core of this biosensor is a phase-sensitive low-coherence spectral-domain interferometer (SD-LCI). The system utilizes a fiber optic probe in a common-path interferometric configuration. This design is key to minimizing phase noise and achieving high sensitivity.

Here's a breakdown of the methodology:

  • Fiber Optic Probe: A custom-designed probe integrates a single-mode fiber, a coverslip, and a stainless-steel tube. The fiber is coupled to a light source, and the coverslip acts as the sensing surface. A detection window allows fluid interaction.
  • Common-Path Interferometry: Incident light from a superluminescent diode (SLD) is delivered to the probe. Interference occurs between light reflected from the fiber-epoxy interface (reference light) and light backscattered from the coverslip-solution interface (sample light). This common path design inherently reduces phase noise compared to systems with separate reference and sample arms.
  • Spectral Domain Detection: The interference signal is collected by a homemade spectrometer and a line-scan charge-coupled device (CCD) camera. This allows for the acquisition of the interference spectrum, which is then processed to extract phase information.
  • Phase Analysis: The interference spectrum is analyzed using Fourier transforms to obtain a path-length-resolved signal. The phase of this signal, $\phi(t) = 2k_0nz(t)$, is directly proportional to the thickness change ($z(t)$) of the molecular layer on the probe surface, where $k_0$ is the wavenumber and $n$ is the refractive index.
  • Fluidic Chip: A polydimethylsiloxane (PDMS) chip with a reaction cavity is designed to hold the sample solution and interface with the fiber optic probe. This allows for controlled delivery of fluids and real-time monitoring.
  • Functionalization: The probe surface is functionalized with a dopamine adhesion layer, followed by protein A for specific binding of target molecules (e.g., IgG), and then a blocking reagent to minimize non-specific binding.

Datasets

Not discussed in the paper. The experiments involved preparing and using specific reagents (protein A, IgG, dopamine-Tris solution, PBS buffer) and solutions at defined concentrations for functionalization and sensing.

Key Insights and Ideas

  • Picometer-Scale Sensitivity: The common-path interferometric design, coupled with phase analysis, allows for the detection of subnanometric changes in molecular layer thickness, translating to picometer-scale sensitivity. This is a significant improvement over many existing label-free methods.
  • Real-Time Monitoring: The system achieves a rapid time response of 13.9 ms, enabling real-time tracking of molecular binding events as they occur. This is crucial for studying reaction kinetics.
  • Tolerance to Concentration Fluctuations: The phase-sensitive nature of the detection method makes it less susceptible to variations in the concentration of the target solution, enhancing robustness.
  • Specific Molecular Recognition: The successful demonstration of protein A binding to IgG highlights the biosensor's capability to specifically identify and quantify target molecules.
  • Label-Free Advantage: The entire process is label-free, eliminating the need for cumbersome and potentially disruptive labeling steps, simplifying experimental workflows.

Key Results

  • Minimum Detectable Concentration (MDC): The biosensor achieved a minimum detectable concentration of IgG of 0.11 µg/mL.
  • Time Response: The system exhibits a rapid time response of 13.9 ms.
  • Phase Stability: Over a 30-minute period with only PBS buffer, the phase fluctuation was less than 0.27 mrad, corresponding to a thickness change of 28 pm in air, demonstrating excellent phase stability.
  • Sensitivity: The linear relationship between IgG concentration and thickness change yielded a slope of 0.056 nm/(µg/mL), which was used to calculate the MDC.
  • Specificity: A comparative experiment showed a significantly larger thickness increase during specific IgG binding to protein A compared to a non-specific binding experiment where protein A was absent, confirming the biosensor's specificity.

Limitations and Future Work

  • Limitations:
    • The current biosensor design is limited in detecting molecules that undergo significant rearrangements of their tertiary structures, as this can affect the measured dimensions.
  • While robust, the system's performance might still be influenced by extreme environmental changes.
  • Future Work:
    • Multi-point Detection: The authors suggest developing systems with multiple reaction cavities and fiber optic probes of varying thicknesses to enable simultaneous pre- and post-reaction information acquisition.
  • Miniaturization: Further miniaturization of the fiber optic probe, potentially by replacing the ceramic ferrule with a thinner glass capillary, is proposed.
  • Broader Applications: Expanding the range of detectable molecules and exploring applications in more complex biological matrices.

Summary updated

Abstract

A phase-sensitive fluidic biosensor based on a spectral-domain low-coherence interferometer is presented in this paper. With a fiber optic probe employing the common-path interferometric configuration, subnanometric changes in thickness of the molecular layers can be detected through phase analysis of the acquired interference signal from the sensor surface. Advantages of this biosensor include its picometer-scale thickness sensitivity, 13.9-ms time response, and tolerance to the fluctuation in concentration of the target solution. The capabilities of this biosensor in monitoring specific molecular binding and recognizing specific molecular was successfully demonstrated by using the reactions between the molecules of protein A and IgG. The calculated minimum detectable concentration of IgG is 0.11 µg/mL.
BibTeX
@inproceedings{guo2018fluidic,
  author = {Cuixia Guo and Xiaojie Yang and Zhiyuan Shen and Jian-Ping Wu and Suyi Zhong and Yonghong He and Tian Guan and Fangyi Chen},
  title = {{A Fluidic Biosensor Based on a Phase-Sensitive Low-Coherence Spectral-Domain Interferometer}},
  booktitle = {Sensors},
  year = {2018},
  url = {https://openreview.net/forum?id=WX4aLHjL1d},
}

Loading related content...

Figure